ONKO

This brand name is authorized in Lithuania, Malta, Poland, Romania

Active ingredients

The drug ONKO contains one active pharmaceutical ingredient (API):

1 Live attenuated mycobacteria BCG (Bacillus Calmette-Guerin), Brazilian Moreau sub-strain
UNII 8VJE55B0VG - BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known.

Read about BCG vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AX03 BCG vaccine L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1089207
Country: MT Medicines Authority Identifier(s): AA1379/00101
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100088227, 100088233
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67983001, W67983002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.